SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024

Rhea-AI Summary

SeaStar Medical Holding (Nasdaq: ICU), a commercial-stage medical device company, will present at NobleCon20, Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference.

The presentation is scheduled for Wednesday, December 4, 2024, at 12:00 p.m. Eastern time (9:00 a.m. Pacific time) in Boca Raton, Fla. The company will provide an overview of its proprietary solutions aimed at reducing the consequences of hyperinflammation on vital organs.

A webcast of the presentation will be available on the company's website starting December 5 and will be archived for 90 days.

News Market Reaction – ICU

+7.98%

+7.98% Session move

In the trading session that priced this news, ICU gained 7.98%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DENVER, Nov. 26, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that management will present a company overview at NobleCon20, Noble Capital Markets’ 20^th Annual Emerging Growth Equity Conference, on Wednesday, December 4 at 12:00 p.m. Eastern time (9:00 a.m. Pacific time). The conference is being held in Boca Raton, Fla.

A webcast of the presentation will be available beginning December 5 on the Company website and will be archived for 90 days.

About SeaStar Medical

SeaStar Medical is a commercial-stage medical technology company that is redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs. SeaStar Medical’s novel technologies rely on science and innovation to provide life-saving solutions to critically ill patients. The Company is developing and commercializing cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. For more information visit www.seastarmedical.com or visit us on LinkedIn or X.

Contact:

Alliance Advisors IR
Jody Cain
(310) 691-7100
Jcain@allianceadvisors.com

# # #

FAQ

When is SeaStar Medical presenting at NobleCon20?

SeaStar Medical is presenting on December 4, 2024, at 12:00 p.m. Eastern time.

Where is NobleCon20 being held?

NobleCon20 is being held in Boca Raton, Fla.

What is the stock symbol for SeaStar Medical?

The stock symbol for SeaStar Medical is ICU.

When will the webcast of SeaStar Medical's presentation be available?

The webcast will be available beginning December 5, 2024, on the company's website.

How long will the webcast of SeaStar Medical's presentation be archived?

The webcast will be archived for 90 days.